PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 16, 2025, the company approved non-statutory stock options ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it raised over $11 million in funding through the exercise of ...

The stock options and RSUs were granted as material inducements to employment in accordance with Nasdaq Listing Rule 5635 (c) ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

MacroGenics (the Company) is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of ...

The Nasdaq 100 notched a record high close on Tuesday for the first time since February, rebounding from deep losses in ...

NQ00 | A complete E-Mini Nasdaq 100 Index Continuous Contract futures overview by MarketWatch. View the futures and commodity market news, futures pricing and futures trading.

As Regency Centers has outperformed the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish ...

As Tapestry has outperformed the Nasdaq recently, analysts remain highly optimistic about the stock’s prospects.